Open access peer-reviewed Edited Volume


Rahul Pratap Singh

GD Goenka University Email


Sunil Kumar Prajapati

Bundelkhand University

Sonali Singh

Guru Teg Bahadur Hospital


Biologicals Monoclonal Antibody Peptides Biomolecules Physicochemical Characterization Healthcare Technology Genetic Engineering Regulatory Recommendations Chemotherapy Biotechnology Innovation Cancer Treatment Safety and Efficacy

Register your interest in contributing to this book

Collaborate with our community and contribute your knowledge.

Register here

15 days remaining

Submissions close on October 30th 2019

About the book

Recent advancement in genetic engineering technology and biotechnology have commonly introduced a new class of therapeutic drugs - biotherapeutics. Such drugs are extracted and/or produced from biological sources and sometimes also known as biological drugs. This has revolutionized modern medicine by providing medicines to treat several complicated and life-threatening diseases like malignancy, cardiovascular associated sickness, infectious illness, respiratory diseases, and chronic inflammation and so on. Biotherapeutics is a rapidly growing class of the total pharmaceutical market and represents a significant portion of recently approved new drugs. The biotherapeutics offers a few phenomenal highlights over the conventional small-molecule pharmaceuticals due to their relatively high specificity, low off-target effects, and bio-compatible metabolism, in addition to legal and logistic advantages. Biotherapeutics include a wide assortment of bioactive molecules, for example, monoclonal antibodies, gene-silencing/editing therapies, recombinant proteins, hormones, cytokines, vaccines, growth factors, tissue-engineered products, and stem cell therapies. These drugs can be modified to improve therapeutic effectiveness of the treatment. This book intends to provide the reader with a comprehensive overview of the current advancement in biotherapeutics, and its therapeutic and biomedical application as well as recent progress and challenges.

Publishing process

Book initiated and editor appointed

Date completed: October 9th 2019

Applications to edit the book are assessed and a suitable editor is selected, at which point the process begins.

Chapter proposals submitted and reviewed

Deadline for chapter proposals: October 30th 2019

Potential authors submit chapter proposals ready for review by the academic editor and our publishing review team.

Register for the book

Approved chapters written in full and submitted

Deadline for full chapters: December 29th 2019

Once approved by the academic editor and publishing review team, chapters are written and submitted according to pre-agreed parameters

Full chapters peer reviewed

Review results due: March 18th 2020

Full chapter manuscripts are screened for plagiarism and undergo a Main Editor Peer Review. Results are sent to authors within 30 days of submission, with suggestions for rounds of revisions.

Book compiled, published and promoted

Expected publication date: May 17th 2020

All chapters are copy-checked and typesetted before being published. IntechOpen regularly submits its books to major databases for evaluation and coverage, including the Clarivate Analytics Book Citation Index in the Web of ScienceTM Core Collection. Other discipline-specific databases are also targeted, such as Web of Science's BIOSIS Previews.

About the editor

Rahul Pratap Singh

GD Goenka University Email

Rahul Pratap Singh studied Pharmacy at Bundelkhand University, Jhansi, India. He did his Ph.D. at Banaras Hindu University, Varanasi, India. He is Assistant Professor of Pharmaceutics at the GD Goenka University, Sohna, Gurugram, India. His awards include “Junior and Senior Research Fellowship 2013-16 for Ph.D. research program funded from University Grants Commission, New Delhi, India”, and “GATE-Scholarship (2009-11) funded from Ministry of Human Resource and Development, New Delhi, India”. He was also awarded with Gandhian Young Technological Innovation - SRISTI Awards, 2017 for Outstanding Achievement in Pharmaceutical Research and Innovation. Dr. Singh’s research focuses on multifunctional nanotechnology-based drug delivery systems, in particular on the receptor-targeted delivery of proteins, peptides and drug delivery, synthesis and physicochemical characterization of nanomedicines, mathematical modelling of system performance, in-vitro and in-vivo safety and efficacy studies, and xenograft modelling for anticancer studies. He has published numerous articles in international scientific journals, and two books. Since 2017, Dr. Singh is an active peer-reviewer and editorial board member for publications in his field.

View profile

Book chapters authored 0

Books edited 0

Introducing your Author Service Manager

Ms. Sara Debeuc

As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact.

Ask a question

Book will be abstracted and indexed in